Volume 5, Issue 1
Review Articlep. 63
Osteoclast-targeted therapy for metastatic prostate cancer
Author(s): Richard J Lee and Matthew R Smith
Appendicesp. 122
Author guidelines: Volume 5 Issue 1
Appendicesp. 119
Indices: Volume 5 Issue 1
Appendicesp. 119
Glossary: Volume 5 Issue 1
Appendicesp. 75
Bulletin board: Volume 5 Issue 1
Appendicesp. 121
Acknowledgment: Volume 5 Issue 1
Review Articlep. 99
Hyperbaric oxygen therapy in the management of nonhealing wounds in patients with critical limb ischemia
Author(s): Gunalp Uzun, Senol Yildiz and Samil Aktas
Drug Evaluationp. 91
Recombinant human epoetin beta in the treatment of renal anemia
Author(s): Lucia Del Vecchio Andrea Cavalli, Pietro Pozzoni and Francesco Locatelli
Drug Evaluationp. 79
Vildagliptin: novel pharmacological approach to treat Type 2 diabetes
Author(s): Bo Ahraain
Review Articlep. 57
Castrate-resistant prostate cancer: the right targets and combinations
Author(s): Joyson Karakunnel and William Dahut
Review Articlep. 47
New directions in endocrine therapy: renewed interest in the androgen receptor
Author(s): Zoran Culig and Alfred Hobisch
Review Articlep. 37
Salvage cryotherapy for recurrent prostate cancer after radiation failure: current status and future perspectives
Author(s): Mohamed Ismail, Pandha Hardev and John Davies
Perspectivep. 25
Avoiding surgery in prostate cancer patients with low-risk disease
Author(s): Vladimir Mouraviev andThomas J Polascik
News and Viewsp. 13
Focus on novel approaches in prostate cancer therapy
Research Highlightsp. 19
Highlights from the latest papers in prostate cancer research
Author(s): Yaacov Richard Lawrence and Adam P Dicker
Editorialp. 7
TGF-�² signaling dictates therapeutic targeting in prostate cancer
Author(s): Natasha Kyprianou
Editorialp. 3
Therapeutic vaccines for prostate cancer: what have we learned?
Author(s): James L Gulley
